Asset

Melphalan hydrochloride

Delcath Systems Inc. Common Stock

Revenue

No revenue reported in loaded filings.

Clinical trials (0)

No records yet.

FDA applications (1)

ApplicationTypeApplicant
NDA 201848NDADELCATH SYSTEMS INC

Marketed products (1)

  • HEPZATO